Spyre Therapeutics stock dips premarket after Friday surge as $500 million shelf hangs over shares
New York, Feb 23, 2026, 08:22 EST — Premarket Spyre Therapeutics dropped 4.2% to $41.38 in premarket action Monday, after its last trade came in at $43.21.